Board Walk.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Works matching IS 03331024 AND DT 2022 AND VI 42 AND IP 1
Results: 14
1
2
Board Walk - January 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
3
Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study.
- Published in:
- Cephalalgia, 2022, v. 42, n. 1, p. 20, doi. 10.1177/03331024211048507
- By:
- Publication type:
- Article
4
The time sequence of brain MRI findings in spontaneous intracranial hypotension.
- Published in:
- Cephalalgia, 2022, v. 42, n. 1, p. 12, doi. 10.1177/03331024211044424
- By:
- Publication type:
- Article
5
CORRIGENDUM to 'Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis'.
- Published in:
- 2022
- Publication type:
- Correction Notice
6
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial.
- Published in:
- Cephalalgia, 2022, v. 42, n. 1, p. 3, doi. 10.1177/03331024211042385
- By:
- Publication type:
- Article
7
Manual joint mobilisation techniques, supervised physical activity, psychological treatment, acupuncture and patient education in migraine treatment. A systematic review and meta-analysis.
- Published in:
- Cephalalgia, 2022, v. 42, n. 1, p. 63, doi. 10.1177/03331024211034489
- By:
- Publication type:
- Article
8
Somatosensory dysfunction in patients with posttraumatic headache: A systematic review.
- Published in:
- Cephalalgia, 2022, v. 42, n. 1, p. 73, doi. 10.1177/03331024211030496
- By:
- Publication type:
- Article
9
Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial.
- Published in:
- Cephalalgia, 2022, v. 42, n. 1, p. 44, doi. 10.1177/03331024211033551
- By:
- Publication type:
- Article
10
E-book review: The end of migraines: 190 ways to stop your pain , by Alexander Mauskop.
- Published in:
- 2022
- By:
- Publication type:
- Book Review
11
Indomethacin has no effect on trigeminally provoked parasympathetic output.
- Published in:
- Cephalalgia, 2022, v. 42, n. 1, p. 37, doi. 10.1177/03331024211030901
- By:
- Publication type:
- Article
12
Aura in trigeminal autonomic cephalalgia is probably mediated by comorbid migraine with aura.
- Published in:
- Cephalalgia, 2022, v. 42, n. 1, p. 31, doi. 10.1177/03331024211030499
- By:
- Publication type:
- Article
13
Measuring headache day severity using multiple features in daily diary designs.
- Published in:
- Cephalalgia, 2022, v. 42, n. 1, p. 53, doi. 10.1177/03331024211033829
- By:
- Publication type:
- Article
14
Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks.
- Published in:
- Cephalalgia, 2022, v. 42, n. 1, p. 82, doi. 10.1177/03331024211029939
- By:
- Publication type:
- Article